Assessing clinical response in multiple myeloma (MM) patients treated with monoclonal antibodies (mAbs): Validation of a daratumumab IFE reflex assay (DIRA) to distinguish malignant M-protein from therapeutic antibody.
暂无分享,去创建一个
T. Plesner | C. McCudden | Sandy Frans | A. Axel | T. Ahmadi | Jordan M. Schecter | K. Sasser | D. Slaets | Jaime Bald